Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aculys, Akeso, Ascentage, Beigene, Brise, Celltrion, Immunoforge, Immutron, Oncolys, Philogen, Taimed, Takeda,Telix.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Asieris, Aslan Pharmaceuticals, Atom Bioscience, Carsgen Therapeutics, Foresee Pharmaceuticals, Genfleet, Hanall Biopharma, I-Mab Biopharma, Innovent Biologics, Meiji Seika Pharm, Samsung Bioepis, Shionogi, Sun Pharmaceutical.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Affamed Therapeutics, Antengene, Asieris Pharmaceuticals, Astrazeneca, Caliway Biopharmaceuticals, Iveric Bio, Recce Pharmaceuticals.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asieris, Caliway, Foresee, Hutchmed, Innocare, J Ints, Sinovac,Takeda, Urovant.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Bristol Myers Squibb, Daiichi Sankyo, Genexine, Lianbio, Recce, Sirnaomics.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bionomics, Clarity, Hutchmed, Kintor, Lynk, Recce, Stempeutics, Zhiyu.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Bio-Thera, Minghui, Neurophth, Qilu, Telix.